Please assess the completion status of the following clinical trial:

Trial Title: Plaque Stabilization and Restoration by Bioresorbable Vascular Scaffold

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Symptomatic patients between the age of 18 and 80 years~* Morise Risk score of ≥9 (intermediate or high risk) but no proven ischemia (no positive troponin or ST-elevation)~* Intermediate coronary lesion on CT scan (50-70% based on CT estimate) and a plaque with at least two of the following vulnerability criteria: Napkin ring sign, positive remodeling, low attenuation and spotty calcification~* FFR negative lesion at coronary angiogram~* Vessel diameter ≥2.5 mm on visual estimate~* GFR ≥ 45mL/min/1.73m².~Exclusion Criteria:~* High calcium score on CT scan preventing adequate evaluation of the coronary lesion.~* Lesions located in a coronary vessels previously stented.~* Lesions located at a bifurcation~* lesions involving an epicardial side branch ≥2 mm in diameter by visual assessment~* the presence of thrombus or another clinically significant stenosis in the target vessel.~* Left main (\>50%) or known three vessel disease.~* Patients presenting with acute myocardial infarction, unstable arrhythmias, or patients who have a left ventricular ejection fraction \<30%~* Intolerance to Aspirin, Clopidogrel, Prasugrel, Ticagrelor, Heparine or Everolimus and known true anaphylaxis to prior contrast media or known bleeding diathesis or known coagulopathy.~* Planned elective surgical procedure necessitating interruption of dual antiplatelet therapy during the first 6 months after inclusion.~* History of stent thrombosis~* Malignancies or other comorbidity with a life expectancy of less than one year or that may result in protocol noncompliance~* Pregnancy (present, suspected or planned) or positive pregnancy test (in women with childbearing potential a negative pregnancy test is mandatory)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Bioresorbable vascular scaffold (Type: EXPERIMENTAL): Implantation of Bioresorbable vascular scaffold in vulnerable plaques

Based on this trial design, predict the completion outcome and termination type (if applicable).